|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 9 of 41 found articles
| Title: |
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC |
| Author: |
Leduc, C. Besse, B. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 25 () nr. 10 pages 2092 |
| Year: |
2014 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 9 of 41 found articles
| << previous | next >> |